ATG13 gene expression level was significantly higher for all groups after ALS, in detail MTEP (3.48-fold), NS-398 (3.90-fold), IMI (2.89-fold), MTEP with NS-398 (3.32-fold), IMI with NS-398 (3.29-fold) (p < 0.001 for each) compared to control and after LPS therapy significantly higher for NS-398 (p < 0.05; 1.96-fold) and IMI (p < 0.05; 1.98-fold) compared to LPS control (Fig. 4H). Here, ATG13 is linked to amyotrophic lateral sclerosis.